http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2235542-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f21c1009c60308a64b8e7dc0bb989632
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
filingDate 2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07249bfa31e9039674ede6ec0670bc98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3f3f2b39641e7bb1d831fe087b3bc4a
publicationDate 2010-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2235542-A1
titleOfInvention Diagnostic in vitro method for assessing von willebrand disease and increased bleeding risk associated with von willebrand disease and acquired or congenital disorders of platelet function
abstract The invention relates to an in-vitro method for diagnosing Von Willebrand Disease (VWD) and an increased bleeding risk associated with von Willebrand Disease and/or acquired or congenital platelet function defects which reduce the interaction of von Willebrand Factor (VWF) with platelets. The in-vitro method of the invention may also be used to diagnose further bleeding risks. The test is suitable for use as a screening test based on whole blood and has the additional benefit of being suitable as a point of care test. The method involves the incubation of a sample containing platelets and haemostasis factors with an activator of platelet aggregation and the measurement of the viscoelastic change after inducing coagulation, e.g. by means of thromboelastography (TEG).
priorityDate 2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226514094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5458428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57201485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127400142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136119730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57092463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226560667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135927382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466

Total number of triples: 37.